Related Experiment Video
Updated: Dec 10, 2025
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
Published on: November 14, 2014
Mechanism-based novel antidotes for organophosphate neurotoxicity
1Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, TX 77807, USA.
Abstract:
This article describes current pursuits for developing novel antidotes for organophosphate (OP) intoxication. Recent mechanistic studies of benzodiazepine-resistant seizures have key consequences for victims of OP pesticide and nerve agent attacks. We uncovered why current therapies are not able to stop the OP-induced seizures and brain cell death and what type of drug might be better. OP exposure down regulates critical inhibitory GABA-A receptors, kills neurons, and causes massive neuroinflammation that will cause more neuronal death, which causes the problem of too few benzodiazepine receptors. The loss of inhibitory interneurons creates a self-sustaining seizure circuit and refractory status epilepticus. Thus, there is an urgent need for mechanism-based, new antidotes for OP intoxication. We have discovered neurosteroids as next-generation anticonvulsants superior to midazolam for the treatment of OP poisoning. Neurosteroids that activate both extrasynaptic and synaptic GABA-A receptors have the potential to stop seizures more effectively and safely than benzodiazepines. In addition, neurosteroids confers robust neuroprotection by reducing neuronal injury and neuroinflammation. The synthetic neurosteroid ganaxolone is being considered for advanced development as a future anticonvulsant for nerve agents. Experimental studies shows striking efficacy of ganaxolone and its analogs in OP exposure models. They are also effective in attenuating long-term neuropsychiatric deficits caused by OP exposure. Overall, neurosteroids represent rational anticonvulsants for OP intoxication, even when given late after exposure.
Insights
Novel neurosteroids offer superior treatment for organophosphate (OP) poisoning, effectively stopping seizures and protecting the brain. These next-generation anticonvulsants are a promising antidote for OP intoxication, even when administered late.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Organophosphate (OP) intoxication causes benzodiazepine-resistant seizures and neurotoxicity due to down-regulation of GABA-A receptors.
- Current therapies are insufficient for treating OP-induced seizures and associated brain cell death.
- Loss of inhibitory interneurons leads to self-sustaining seizure circuits and refractory status epilepticus.
Purpose of the Study:
- To investigate the mechanisms underlying OP-induced seizures and neurotoxicity.
- To identify novel therapeutic strategies and potential antidotes for OP intoxication.
- To evaluate the efficacy of neurosteroids as next-generation anticonvulsants for OP poisoning.
Main Methods:
- Mechanistic studies on benzodiazepine-resistant seizures in OP intoxication models.
- Evaluation of neurosteroids, including ganaxolone and its analogs, as potential antidotes.
- Experimental studies in OP exposure models to assess anticonvulsant and neuroprotective effects.
Main Results:
- Neurosteroids effectively activate both extrasynaptic and synaptic GABA-A receptors, offering superior seizure control compared to benzodiazepines.
- Neurosteroids demonstrate robust neuroprotection by reducing neuronal injury and neuroinflammation.
- Ganaxolone and its analogs show significant efficacy in OP exposure models, mitigating acute symptoms and long-term neuropsychiatric deficits.
Conclusions:
- Neurosteroids represent a rational, mechanism-based approach for treating OP intoxication.
- These compounds are effective anticonvulsants and neuroprotectants, even when administered late after exposure.
- The synthetic neurosteroid ganaxolone is a promising candidate for advanced development as a future antidote for nerve agent exposure.
More Related Videos
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
01:17Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...